Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia, Lymphoid

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,016 public trials 548 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Recruiting

CAV Regimen for R/R Ph- B-ALL

NCT05657652

Conditions: Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +13 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

A Study of Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT02966756

Conditions: Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +16 more
Locations: Concord Repatriation General Hospital /ID# 201261 Concord, New South Wales, Australia

St George Hospital /ID# 206484 Kogarah, New South Wales, Australia

Monash Health - Monash Medical Centre /ID# 201263 Clayton, Victoria, Australia

Anhui Provincial Cancer Hospital /ID# 209458 Hefei, Anhui, China

View all 31 locations

View Trial Details

Recruiting

Anti-CCR9 CAR T Cells for T Cell Leukaemia/Lymphoma

NCT07300683

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations: University College London Hospitals London, United Kingdom

View Trial Details

Recruiting

CAYA Cancer Retrospective Cohort Study

NCT07246213

Conditions: Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia (ALL), Adolescent Cancer, +15 more
Locations: Yeolyan Center for Cancer and Blood Disorders Yerevan, Armenia

Fundación Ayúdame a Vivir El Salvador

Unidad Nacional de Oncología Pediátrica (UNOP) Guatemala City, Guatemala

Hospital Mario Catarino Rivas San Pedro Sula, Cortés Department, Honduras

View Trial Details

Recruiting

Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL

NCT06387121

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies

NCT07284927

Conditions: Acute Lymphoblastic Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +12 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Recruiting

Venetoclax Combined With Azactidine in the Treatment of ALAL

NCT05901974

Conditions: Acute Leukemia of Ambiguous Lineage, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: The First Affliated Hospital of Soochow University Suzhou, China

View Trial Details

Recruiting

Acalabrutinib for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT06757647

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Disease Attributes, +14 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

Mosunetuzumab for CLL MRD Clearance

NCT07052695

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: Brigham & Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

NCT05602363

Conditions: B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +34 more
Locations: UC Irvine Health Orange, California, United States

Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

Northwestern Memorial Hospital Chicago, Illinois, United States

View all 13 locations

View Trial Details